Supply chain leaders call for forward pharma thinking
pharmafile | September 11, 2015 | News story | Manufacturing and Production, Medical Communications | fly pharma, fly pharma conference, logistics, supply chain
Logistics companies must improve their understanding of the pharma industry to better serve their customers, according to a supply chain expert.
IJS Global’s director Naomi Landman told delegates at the FlyPharma Conference in that the industry is going through a ‘major transition’ – and that pharma companies and logistics firms must adapt to reflect the changes.
This will mean moving away from a one-size-fits all model to one built carefully around individual care, personalisation, and wellness, she told delegates.
“We need to come together and collectively broaden our understanding of the pharma supply chain and not just focus on the freight aspects,” she said.
She believes technological advances, as well as tax, regulatory, and market demands are driving change and making the pharmaceutical supply chain more complex. Supply chain solutions must be flexible and reliable, and providers must be able to create bespoke solutions based on a clear understanding of the customer and their business, Landman said.
Landman added that IJS Global has recruited logistics specialists from the pharma industry bringing first-hand knowledge and experience claiming: “This has enhanced our ability to offer flexible and efficient solutions that maintain product integrity.”
She added: “Pharmaceutical logistics is a demanding, time critical industry that requires the immediate availability of insight whilst appreciating the client’s sensitive needs and requirements.”
Landman said that logistics companies should also make it a priority to be up to date with the most current issues and trends in the pharma industry to enable them to come up with fast, effective solutions.
In a keynote speech Geert Petermans, who is global supply chain operational excellence director, told delegates that “the traditional fragmented pharma logistics chain needs to be replaced by a lean, fully integrated, positively aligned, goal-sharing, risk-sharing, mutually trusting, win-win strategic coalition.”
Yasmita Kumar
Related Content
Medicines recalled after FMD alert
The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots …
No-deal Brexit could cause shortages and higher prices, healthcare distributors warn
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines …
The missing link: Blockchain in clinical data management
Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to …
